RareWays is a research directory. It helps you understand the science. It is not medical advice. Always discuss your care options with your healthcare team.
Coverage: 2020-01-01 onwards, with up to 300 results per query from PubMed and Europe PMC and separate limits on other sources. This is a selected index, not a complete literature search.
Updates are delayed or unverified. Check original sources for the latest information.
Your saved research and appointment questionsView recorded trial and retraction changes
Familial Mediterranean Fever: Research Summary
Printed from RareWays (rareways.org)
For general awareness only. Not medical advice. Discuss all care options with your healthcare team.
5 Most Recent Research Articles
- 1.
WNK1 links ionic signals to microtubule dynamics to control pyrin inflammasome assembly
Lewis G et al. (16 October 2026)
https://europepmc.org/search?query=WNK1%20links%20ionic%20signals%20to%20microtubule%20dynamics%20t
- 2.
Association between serum transaminase elevations and clinical course in patients with familial Mediterranean fever.
Şentürk Öztaş Nihan et al., Clinical and experimental rheumatology (15 October 2026)
https://pubmed.ncbi.nlm.nih.gov/42886599/
- 3.
Is Hair Colchicine Dosing Effective for Tracking Compliance in Children with Familial Mediterranean Fever?
Hentgen Véronique et al., Joint bone spine (13 October 2026)
https://pubmed.ncbi.nlm.nih.gov/42869206/
- 4.
Comparative Performance of CBC-Derived Inflammatory Indices for Detecting Persistent subclinical inflammation in Children with Familial Mediterranean Fever
Heba Abdelaty et al., Research Square (11 October 2026)
https://doi.org/10.21203/rs.3.rs-11127335/v1
- 5.
Clinical and MEFV variant characteristics of pediatric patients with an FMF-compatible phenotype and PFAPA-compatible features in a Palestinian referral cohort: a retrospective study
Ahmad K. Abuhammad et al., Scientific Reports (10 October 2026)
https://doi.org/10.1038/s41598-026-75387-2
Source: RareWays research directory. Data from PubMed, Europe PMC, OpenAlex, ClinicalTrials.gov.
Always verify information with your healthcare team before making any decisions about your care.
Familial Mediterranean Fever
Familial Mediterranean Fever is the most common hereditary autoinflammatory disease, caused by mutations in the MEFV gene. It causes recurrent episodes of fever and serositis (painful inflammation of the lining of the abdomen, chest, or joints). It predominantly affects people of Mediterranean and Middle Eastern descent. Colchicine is highly effective in preventing attacks and reducing amyloid risk.
This overview is general information, not an individual medical assessment. Research is selected automatically and may include mismatches. How we select and explain research.
Most Recent Research
Common Questions
What is Familial Mediterranean Fever?
Familial Mediterranean Fever is the most common hereditary autoinflammatory disease, caused by mutations in the MEFV gene. It causes recurrent episodes of fever and serositis (painful inflammation of the lining of the abdomen, chest, or joints). It predominantly affects people of Mediterranean and Middle Eastern descent. Colchicine is highly effective in preventing attacks and reducing amyloid risk.
How many clinical trials are available for Familial Mediterranean Fever?
RareWays currently indexes 32 clinical trials for Familial Mediterranean Fever, of which 6 are actively recruiting. These counts cover indexed trials across countries, not just your country. An Australian site does not necessarily mean that site is recruiting. Check locations, eligibility and current availability with the study team.
Where does the research data for Familial Mediterranean Fever come from?
RareWays aggregates research from PubMed, Europe PMC, OpenAlex, and ClinicalTrials.gov. Data is refreshed automatically every day. All articles and trials link directly to their original sources.
Get research updates
Monthly email when new findings are published for Familial Mediterranean Fever.
Your email and selected disease are stored for these updates. Unsubscribe any time. Privacy and deletion.
This information is for general awareness only.
For guidance specific to your situation, please speak with your healthcare team.